• CAS No.：
  1599472-25-9
• Synonyms：
  Mal-PEG6-NHS ester
  
• Purity：
  ≥95%
• MF：
  C₂₃H₃₄N₂O₁₂
• MW：
  530.5
• Recommended Storage Condition：
  Store at -5°C,keep in dry and avoid sunlight.
• Uses：
  Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Cited Publications

This PEG derivative has been cited in peer-reviewed scientific publications. Browse the references below to learn more.

1. Tikum AF, Henning NW, Pougoue Ketchemen J, et al. An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer. Cancer Res. Published online March 24, 2025. doi:10.1158/0008-5472.CAN-24-2266 
2. Pougoue Ketchemen J, Njotu FN, Babeker H, et al. Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate. Clin Cancer Res. 2025;31(4):685-696. doi:10.1158/1078-0432.CCR-24-1779 
3. Tikum, A. F., Nambisan, A. K., Ketchemen, J. P., Babeker, H., Khan, M. N., Torlakovic, E. E., & Fonge, H. (2022). Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics, 14(9), 1917. https://doi.org/10.3390/pharmaceutics14091917 
4. Preclinical Evaluation of 111In-labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-positive Cancer Models, Siddesh V Hartimath, Elahe Alizadeh, Viswas Raja Solomon, Rufael Chekol, Wendy Bernhard, Wayne Hill, Angel Parada Casaco, Kris Barreto, Clarence Ronald Geyer, Humphrey Fonge, Journal of Nuclear Medicine Jan 2019, jnumed.118.220095; DOI: 10.2967/jnumed.118.220095

View more publications citing Biopharma PEG products.